IP Library Granted Patent US 7,504,489
Granted Patent B2
US 7,504,489 · App. 11/294,932 · Granted Mar 17, 2009

Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,489
App. No.
11/294,932
Granted
Mar 17, 2009
Kind
B2
Abstract

The present invention provides compounds having the formula: wherein A is chosen from a nitrogen-, oxygen-, or sulfur-linked aryl, alkyl, cyclic, or heterocyclic group; both B and C are hydrogen, or either B or C is a halogen, amino, or thiol group and the other of B or C is hydrogen; and D is a primary alcohol, a hydrogen, or an oxygen, nitrogen, carbon, or sulfur linked to phosphate, a phosphoryl group, a pyrophosphoryl group, or adenosine monophosphate through a phosphodiester or carbon-, nitrogen-, or sulfur-substituted phosphodiester bridge, or to adenosine diphosphate through a phosphodiester or carbon-, nitrogen-, or sulfur-substituted pyrophosphodiester bridge. The present invention also provides pharmaceutical compositions containing the above compounds, methods of using the above compounds as pharmaceuticals, and processes for preparing the above compounds. Also provided are methods for inhibiting an ADP-ribosyl transferase, ADP-ribosyl cyclase, or ADP-ribosyl hydrolase enzyme, and methods for treating a disease or condition associated with an ADP-ribosyl transferase, ADP-ribosyl cyclase, or ADP-ribosyl hydrolase enzyme in a subject in need of treatment thereof.

Claims (14)

1. A compound represented by the formula:

wherein

A is —S—Y or —O—Y, wherein Y is a substituted phenyl group, a substituted pyridyl group, a nicotinamide group, or a hydroxy-substituted nicotinamide group and wherein the phenyl group is substituted with a halogen, thiol, amino, oxygen or carboxyamine;

B is hydrogen, or a halogen, or an amino group;

C is hydrogen, or a halogen, or an amino group; and

D is a primary alcohol, a hydrogen, or an oxygen, nitrogen, carbon, or sulfur linked to phosphate, a phosphoryl group, a pyrophosphoryl group, or adenosine monophosphate through a phosphodiester or carbon-, nitrogen-, or sulfur-substituted, phosphodiester bridge, or to adenosine diphosphate through a phosphodiester or carbon-, nitrogen-, or sulfur-substituted pyrophosphodiester bridge.

2. The compound of claim 1 , wherein A is —O—Y.

3. The compound of claim 1 , wherein A is —S—Y.

4. The compound of claim 2 , wherein both B and C are hydrogen, or either B or C is a halogen or an amino group and the other of B or C is hydrogen.

5. The compound of claim 3 , wherein both B and C are hydrogen, or either B or C is a halogen or an amino group and the other of B or C is hydrogen.

6. The compound of claim 2 , wherein D is a primary alcohol or hydrogen.

7. The compound of claim 3 , wherein D is a primary alcohol or hydrogen.

8. The compound of claim 1 , wherein both B and C are hydrogen, or either B or C is a halogen or an amino group and the other of B or C is hydrogen.

9. The compound of claim 1 , wherein D is a primary alcohol or hydrogen.

Assignments (3)
CHANGE OF NAME Recorded Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036887/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036865/0901 →
CONFIRMATORY LICENSE Recorded Aug 3, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036252/0395 →